 | Immuneering Corporation | |||
| NGM : IMRX || Location: United States | ||||
$1.8+0.03 (+1.69%) |
0.52 M | 1.56 - 1.82 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.876 M |
| March 15, 2024 | 2.610 M |
| Feb. 29, 2024 | 2.685 M |
| Feb. 15, 2024 | 2.703 M |
| Jan. 31, 2024 | 2.673 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.48 | -0.52 | -9.08% |
| 09/30/2023 | -0.50 | -0.43 | 14.61% |
| 06/30/2023 | -0.54 | -0.43 | 20.09% |
| 03/31/2023 | -0.57 | -0.51 | 10.71% |
| 12/31/2022 | -0.59 | -0.50 | 14.85% |
IMRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 29.283M | Shares Float | 15.652M |
| Short Float | 2.876M | Market Cap | 51.83M |
| Institution ownership | 42.35% | Insider ownership | 29.546% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.88 | Forward EPS | -1.92 |